Development of potent SHP2 inhibitors for in vivo studies

被引：0
|
作者：
Ge, Yiyu [1 ]
Lawrence, Harshani R. [1 ]
Chen, Liwei [1 ]
Scott, Latanya M. [1 ]
Sebti, Said M. [1 ]
Lawrence, Nicholas J. [1 ]
Wu, Jie [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2912
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2912
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Sidestepping SHP2 inhibition
    Popescu, Bogdan
    Shannon, Kevin
    JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 220 (05):
  • [42] Crystallographic landscape of SHP2 provides molecular insights for SHP2 targeted drug discovery
    Song, Yihui
    Yang, Xinyu
    Wang, Shu
    Zhao, Min
    Yu, Bin
    MEDICINAL RESEARCH REVIEWS, 2022, 42 (05) : 1781 - 1821
  • [43] Selective Inhibitors of the Protein Tyrosine Phosphatase SHP2 Block Cellular Motility and Growth of Cancer Cells in vitro and in vivo
    Grosskopf, Stefanie
    Eckert, Chris
    Arkona, Christoph
    Radetzki, Silke
    Boehm, Kerstin
    Heinemann, Udo
    Wolber, Gerhard
    von Kries, Jens-Peter
    Birchmeier, Walter
    Rademann, Joerg
    CHEMMEDCHEM, 2015, 10 (05) : 815 - 826
  • [44] Toward a Treatment of Cancer: Design and In Vitro/In Vivo Evaluation of Uncharged Pyrazoline Derivatives as a Series of Novel SHP2 Inhibitors
    Dai, Jiajia
    Zhang, Yiting
    Gao, Yanan
    Bai, Xiaoyi
    Liu, Fang
    Li, Shuo
    Yu, Yanyan
    Hu, Wenpeng
    Shi, Ting
    Shi, Dayong
    Li, Xiangqian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [45] Bivalent target-binding bioPROTACs induce potent degradation of oncogenic SHP2
    Hoffman, Megan
    Krum, David
    Wittrup, K. Dane
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (09)
  • [46] SHP2-EGFR States in Dephosphorylation Can Inform Selective SHP2 Inhibitors, Dampening RasGAP Action
    Liu, Yonglan
    Jang, Hyunbum
    Nussinov, Ruth
    JOURNAL OF PHYSICAL CHEMISTRY B, 2024, 128 (21): : 5175 - 5187
  • [47] SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition
    Lai, Xianning
    Lui, Sarah Kit Leng
    Lam, Hiu Yan
    Adachi, Yuta
    Sim, Wen Jing
    Vasilevski, Natali
    Armstrong, Nicola J.
    Bridgeman, Stephanie Claire
    Main, Nathan Michael
    Tan, Tuan Zea
    Tirnitz-Parker, Janina E. E.
    Thiery, Jean Paul
    Ebi, Hiromichi
    Kumar, Alan Prem
    Eichhorn, Pieter Johan Adam
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [48] BPI-442096: A potent and selective inhibitor of SHP2 for the treatment of multiple cancers
    Li, Ling
    Fu, Bang
    Han, Han
    Sun, Zhongxin
    Zhao, Xiangdong
    Jv, Xuepeng
    Tong, Jun
    Zhao, Jiayu
    Zou, Zhengyao
    Chen, Haibo
    Liu, Xiaoyun
    Ren, Wei
    Li, Yinlong
    Wu, Wenmao
    Guo, Jing
    Yan, Dan
    Liu, Xiangyong
    Lan, Hong
    Wu, Hao
    Ding, Lieming
    Wang, Jiabing
    CANCER RESEARCH, 2022, 82 (12)
  • [49] Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening
    Yu, Zhi-Hong
    Chen, Lan
    Wu, Li
    Liu, Sijiu
    Wang, Lina
    Zhang, Zhong-Yin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4238 - 4242
  • [50] SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition
    Xianning Lai
    Sarah Kit Leng Lui
    Hiu Yan Lam
    Yuta Adachi
    Wen Jing Sim
    Natali Vasilevski
    Nicola J. Armstrong
    Stephanie Claire Bridgeman
    Nathan Michael Main
    Tuan Zea Tan
    Janina E. E. Tirnitz-Parker
    Jean Paul Thiery
    Hiromichi Ebi
    Alan Prem Kumar
    Pieter Johan Adam Eichhorn
    npj Precision Oncology, 7
12345